BPC-157 is a synthetic peptide of 15 amino acids. Its name stands for “Body Protection Compound”: the sequence is a fragment of a larger protein first described in gastric juice. It is one of the most-studied research peptides, and most of the published work comes from animal and cell models.
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Structure
| Property | Value |
|---|---|
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Length | 15 amino acids (pentadecapeptide) |
| Molecular formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular weight | ~1419.5 g/mol |
| Other names | PL 14736, Bepecin |
BPC-157 is unusually stable for a peptide of its size. In laboratory studies it stays intact in gastric juice, which is one reason researchers have studied it in gut models.
What research has looked at
Most BPC-157 research comes from a few groups, mainly the University of Zagreb, and was done in rodents and cell cultures. The main areas are:
- Gastrointestinal models. Ulcers, lesions and anastomosis healing in rodents. This is where the work started, given the peptide’s gastric origin.
- Tendon, ligament and muscle models. Healing of transected or injured tendons and ligaments in rats, and studies of tendon fibroblasts in culture.
- Blood-vessel formation (angiogenesis). Studies of how BPC-157 relates to VEGF receptor signaling and to the nitric oxide system.
- Interactions with other systems. Work on the dopamine and serotonin systems in animal models.
Limits of the evidence
- Almost all published data are preclinical (animal and cell models). Human data are limited to small, uncontrolled pilot reports, such as a 2025 intravenous safety pilot with two participants. No controlled clinical trial results have been published.
- Much of the literature comes from one research group, and independent replication is limited.
- BPC-157 is not approved by the FDA for any use.
- It is named on the World Anti-Doping Agency’s 2026 Prohibited List under S0 (non-approved substances), so it is prohibited at all times.
Researchers should read the primary literature directly. PubMed lists the original studies under “BPC 157”.
Forms OmegAmino supplies
| Form | Amount |
|---|---|
| Lyophilized powder | 10 mg vial |
| Capsules | 60 × 500 mcg |
| In blends | GLOW (with GHK-Cu and TB-500), Mutant (with TB-500 and KPV) |
Every batch is third-party tested for identity and purity. You can look up the Certificate of Analysis for the BPC-157 we supply at omegamino-coas.com. Read more about how we test.
Storage
Store lyophilized peptide sealed and refrigerated, kept cool, dark and away from moisture. We don’t recommend home freezers: their defrost cycles warm and cool the contents repeatedly, which can damage peptides. Once reconstituted, keep the solution refrigerated and use it within the period your protocol specifies. Capsules: store cool, dry and sealed.
Related research
- TB-500, often studied alongside BPC-157 in tissue models
- KPV
- All research overviews
Researchers with an account can order from the shop.
